CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 11,438 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average daily volume of 48 shares, the days-to-cover ratio is presently 238.3 days.
CanSino Biologics Stock Performance
CASBF stock opened at C$3.15 on Friday. CanSino Biologics has a 52 week low of C$2.60 and a 52 week high of C$6.99. The firm’s 50-day moving average is C$3.01 and its two-hundred day moving average is C$3.71.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development and commercialization of vaccine products. Headquartered in Tianjin, the company leverages an adenovirus vector platform to develop single-dose and recombinant vaccines targeting a range of infectious diseases. CanSino’s pipeline includes its authorized COVID-19 vaccine, Convidecia (Ad5-nCoV), as well as candidates for Ebola, influenza and other pathogens.
Since its founding in 2009, CanSino has built end-to-end capabilities spanning antigen discovery, process development and large-scale manufacturing.
See Also
- Five stocks we like better than CanSino Biologics
- L3Harris’ Record Backlog Makes Its Stock Sell-Off Look Overdone
- Quantum Earnings Could Decide Whether the Sector’s Sell-Off Has Gone Too Far
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
